Stuart J. Schnitt

Stuart J. Schnitt's AcademicInfluence.com Rankings

Stuart J. Schnitt

Biology

#6378

World Rank

#9077

Historical Rank

Pathology

#77

World Rank

#164

Historical Rank

biology Degrees

Download Badge

Biology

Stuart J. Schnitt's Degrees

Doctorate Medicine Harvard University

Why Is Stuart J. Schnitt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stuart J. Schnitt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Molecular definition of breast tumor heterogeneity. (2007) (1415)
Molecular characterization of the tumor microenvironment in breast cancer. (2004) (1287)
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. (2000) (1104)
Breast cancer prognostic classification in the molecular era: the role of histological grade (2010) (749)
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. (1995) (663)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists (2011) (629)
A Nonapoptotic Cell Death Process, Entosis, that Occurs by Cell-in-Cell Invasion (2007) (565)
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. (2000) (564)
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. (1994) (559)
Regulation of in situ to invasive breast carcinoma transition. (2008) (521)
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. (2006) (506)
Magnetic resonance imaging of the breast prior to biopsy. (2004) (506)
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. (1999) (497)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer (2014) (490)
Diagnostic concordance among pathologists interpreting breast biopsy specimens. (2015) (487)
The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy (1994) (465)
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (2014) (457)
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. (1990) (424)
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. (1992) (421)
Interobserver Reproducibility in the Diagnosis of Ductal Proliferative Breast Lesions Using Standardized Criteria (1992) (414)
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy (2010) (412)
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothe (2017) (408)
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (2014) (394)
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. (1999) (394)
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging (2005) (392)
Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. (2011) (356)
Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy (1984) (346)
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. (1999) (330)
The 2019 World Health Organization classification of tumours of the breast (2020) (330)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer (2008) (328)
Skin‐Sparing Mastectomy and Immediate Reconstruction: Oncologic Risks and Aesthetic Results in Patients with Early‐Stage Breast Cancer (1998) (326)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women (2011) (321)
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2014) (309)
Phyllodes tumours of the breast: a consensus review (2016) (305)
Androgen Receptor Expression in Breast Cancer in Relation to Molecular Phenotype: Results from the Nurses’ Health Study (2011) (298)
Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise? (2002) (297)
Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma (2002) (295)
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. (1996) (292)
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. (1990) (290)
Molecular markers in ductal carcinoma in situ of the breast. (2003) (290)
Microvessel density and distribution in ductal carcinoma in situ of the breast. (1994) (285)
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer (2011) (276)
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy (2005) (269)
Radial scars in benign breast-biopsy specimens and the risk of breast cancer. (1999) (262)
Ductal carcinoma in situ (intraductal carcinoma) of the breast. (1988) (260)
Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy (1996) (257)
Columnar Cell Lesions of the Breast (2003) (252)
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. (1997) (252)
Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer (2007) (249)
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. (2004) (241)
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ (2016) (240)
Location of BRCA1 in Human Breast and Ovarian Cancer Cells (1996) (240)
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. (1986) (238)
Pathologic findings on re‐excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy (1987) (229)
Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast (1997) (228)
Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. (1990) (224)
Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer (2006) (215)
Defining the cellular precursors to human breast cancer (2011) (214)
Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. (1998) (213)
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. (2011) (211)
Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. (1985) (210)
Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. (1993) (207)
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer (2011) (204)
Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. (1988) (204)
Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast (2009) (199)
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ (2016) (190)
Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines (2010) (190)
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group (2016) (189)
The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. (1988) (182)
Taxonomy of breast cancer based on normal cell phenotype predicts outcome. (2014) (180)
Surgical margins in lumpectomy for breast cancer--bigger is not better. (2012) (180)
Prospective study of wide excision alone for ductal carcinoma in situ of the breast. (2006) (179)
Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers (2006) (174)
Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. (2001) (170)
Contralateral breast cancer: clinical characteristics and impact on prognosis. (1993) (167)
MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883 (2005) (166)
Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. (2005) (162)
The diagnosis and management of pre-invasive breast disease: Flat epithelial atypia – classification, pathologic features and clinical significance (2003) (161)
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342 (2006) (152)
A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer (1996) (149)
A non-genetic route to aneuploidy in human cancers (2011) (147)
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study (2011) (145)
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells (2001) (143)
Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy (2017) (143)
The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. (1991) (141)
Biopsy Interpretation of the Breast (2008) (140)
Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) (2002) (140)
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma (2004) (140)
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. (2009) (139)
Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia (2007) (138)
Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial (2005) (131)
Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. (1989) (130)
Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. (1987) (130)
Carcinomas In Situ of the Breast With Indeterminate Features: Role of E-Cadherin Staining in Categorization (2001) (129)
Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. (2000) (125)
Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. (1985) (122)
Evolutionary pathways in BRCA1-associated breast tumors. (2012) (120)
Expression of interleukin‐1β in human breast carcinoma (1997) (118)
Results of treating ductal carcinoma In situ of the breast with conservative surgery and radiation therapy (1991) (118)
Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast (2009) (118)
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. (2000) (117)
Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry (2013) (117)
Meningiomas Diagnostic Value of Immunoperoxidase Staining for Epithelial Membrane Antigen (1986) (112)
Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues (1996) (110)
Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS) (2013) (110)
Papillary and neuroendocrine breast lesions: the WHO stance (2015) (109)
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice (2020) (108)
Psoriasin expression in mammary epithelial cells in vitro and in vivo. (2002) (106)
Processing and evaluation of breast excision specimens. A clinically oriented approach. (1992) (105)
Long-term results of directional coronary atherectomy: predictors of restenosis. (1992) (105)
Computational Pathology to Discriminate Benign from Malignant Intraductal Proliferations of the Breast (2014) (104)
Expression of scatter factor and c‐met receptor in benign and malignant breast tissue (1997) (104)
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. (1996) (103)
The Use of Pathologic Features in Selecting the Extent of Surgical Resection Necessary for Breast Cancer Patients Treated by Primary Radiation Therapy (1985) (102)
Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. (1987) (101)
The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions. (2017) (101)
The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. (1994) (99)
Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression (2008) (98)
Meningeal melanocytoma. Case report and review of the clinical and histological features. (1987) (98)
Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. (2004) (97)
Current management of lesions associated with an increased risk of breast cancer (2015) (97)
A putative role for psoriasin in breast tumor progression. (2005) (94)
Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. (1999) (91)
Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. (2008) (90)
Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. (1995) (89)
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features (2010) (88)
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ. (2016) (88)
Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma (1998) (87)
p53 antigen loss in stored paraffin slides. (1995) (87)
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. (2001) (86)
The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy (2000) (86)
The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy (2004) (85)
Developing a prognostic index for ductal carcinoma in situ of the breast: Are we there yet? (1996) (85)
Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy (1989) (84)
Estrogen receptor immunohistoohemistry in carcinoma in situ of the breast (2010) (84)
Thyroid Transcription Factor-1 Expression in Breast Carcinomas (2010) (82)
Expression of interleukin-1beta in human breast carcinoma. (1997) (82)
Benign Breast Disease and Breast Cancer Risk: Morphology and Beyond (2003) (82)
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity. (2016) (81)
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. (2005) (80)
Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel (2014) (80)
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. (2013) (80)
Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. (1985) (79)
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. (1997) (79)
Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers (2011) (79)
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin (2011) (79)
Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. (1998) (77)
Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast (2006) (77)
Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? (1998) (77)
Lobular carcinoma in situ: current concepts and controversies. (1999) (74)
Breast Cancer in the 21st Century: Neu Opportunities and Neu Challenges (2001) (74)
Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers (2009) (74)
Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. (1986) (74)
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study (2011) (73)
Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. (1989) (72)
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial). (2020) (72)
Traditional and newer pathologic factors. (2001) (72)
The influence of family history on breast cancer risk in women with biopsy‐confirmed benign breast disease (2006) (71)
Diagnostic Agreement in the Evaluation of Image-guided Breast Core Needle Biopsies: Results from a Randomized Clinical Trial (2004) (70)
Rapid microwave fixation of human tissues for light microscopic immunoperoxidase identification of diagnostically useful antigens. (1987) (70)
Breast‐conserving therapy for Stage I‐II synchronous bilateral breast carcinoma (1997) (69)
Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk (2013) (68)
Assessment of pathologic prognostic factors in breast core needle biopsies. (1999) (68)
Phenotypic Alterations in Ductal Carcinoma In Situ-associated Myoepithelial Cells: Biologic and Diagnostic Implications (2009) (68)
(99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. (2002) (67)
Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. (1987) (66)
A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. (2006) (65)
Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast‐conserving therapy (1996) (64)
Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. (1992) (63)
Laser balloon angioplasty: clinical, angiographic and histologic results. (1991) (63)
Current status of HER2 testing: caught between a rock and a hard place. (2001) (63)
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98 (2019) (63)
Extensive apoptosis in ductal carcinoma in situ of the breast (1996) (62)
The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. (2000) (62)
The relationship between shaved margin and inked margin status in breast excision specimens (1997) (61)
Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy. (1992) (61)
Radiation-induced changes in the breast. (1984) (61)
Clinical-pathologic study of early breast cancer treated by primary radiation therapy. (1983) (61)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020) (60)
The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin (2009) (60)
Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. (1990) (60)
Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ (2013) (60)
Ultrahigh-resolution and 3-dimensional optical coherence tomography ex vivo imaging of the large and small intestines. (2005) (59)
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020) (2016) (58)
Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients (2007) (58)
Skin recurrences after breast-conserving therapy for early-stage breast cancer. (1998) (58)
E‐cadherin immunohistochemistry in breast pathology: uses and pitfalls (2016) (58)
Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? (1989) (56)
Phenotypic Alterations in Myoepithelial Cells Associated With Benign Sclerosing Lesions of the Breast (2010) (55)
Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. (2000) (55)
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer (2010) (55)
Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. (1993) (54)
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group (2020) (54)
Estrogen receptor testing of breast cancer in current clinical practice: what's the question? (2006) (54)
Adolescent diet and incidence of proliferative benign breast disease. (2003) (53)
Early Life Factors and Incidence of Proliferative Benign Breast Disease (2005) (53)
Family history of breast cancer, age and benign breast disease (2002) (51)
Local control following breast-conserving surgery for invasive cancer: results of clinical trials. (1995) (51)
Genetic variation and circulating levels of IGF‐I and IGFBP‐3 in relation to risk of proliferative benign breast disease (2010) (50)
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. (2004) (50)
Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies (2013) (50)
HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy (2005) (49)
The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. (1996) (48)
Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk (2000) (48)
Histologic findings in specimens obtained by percutaneous directional coronary atherectomy. (1992) (48)
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. (2013) (47)
Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease (2010) (47)
Predictors of local recurrence following excision alone for ductal carcinoma in situ (1999) (47)
How Thoroughly Should Needle Localization Breast Biopsies Be Sampled for Microscopic Examination?: A Prospective Mammographic/Pathologic Correlative Study (1990) (47)
Genetic Analysis of Microglandular Adenosis and Acinic Cell Carcinomas of the Breast Provides Evidence for the Existence of a Low-grade Triple-Negative Breast Neoplasia Family (2016) (46)
Association of age and reproductive factors with benign breast tissue composition. (1999) (45)
Lobule type and subsequent breast cancer risk: Results from the Nurses' Health Studies (2009) (44)
bcl‐2 expression in the spectrum of preinvasive breast lesions (1996) (44)
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers (2010) (44)
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations (2016) (43)
Conservative surgery and radiation therapy for early breast cancer. (1987) (43)
Histologic Sampling of Grossly Benign Breast Biopsies: How Much Is Enough? (1989) (43)
Nature and significance of cells with irregular nuclear contours in esophageal mucosal biopsies. (1992) (42)
Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies (2016) (42)
Columnar cell lesions and subsequent breast cancer risk: a nested case-control study (2010) (40)
Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? (2013) (40)
Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study (2014) (40)
Does Isolated Flat Epithelial Atypia on Vacuum‐assisted Breast Core Biopsy Require Surgical Excision? (2014) (39)
Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer. (1998) (39)
Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. (2007) (38)
Angiogenesis in Preinvasive Lesions of the Breast (1996) (38)
Intakes of Alcohol and Folate During Adolescence and Risk of Proliferative Benign Breast Disease (2012) (36)
Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going? (2003) (36)
Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. (1993) (36)
Quantitation of lymphocytes in endomyocardial biopsies: use and limitations of antibodies to leukocyte common antigen. (1987) (36)
bcl-2 expression in the spectrum of preinvasive breast lesions. (1996) (34)
Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. (2002) (34)
Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer (2016) (34)
A prospective study of diet and benign breast disease. (2004) (34)
Benign breast disease resolved and unresolved issues (1993) (34)
Significance Analysis of Prognostic Signatures (2013) (33)
The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection? (2000) (32)
Accuracy of Touch Imprint Cytology of Image-Directed Breast Core Needle Biopsies (1999) (32)
Principles of Cancer Pathology (2003) (32)
DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer (2010) (32)
In situ carcinoma of the breast. (1989) (32)
Microinvasive carcinoma of the breast: a diagnosis in search of a definition. (1998) (31)
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer. (2022) (31)
Mammary Ducts in the Areola: Implications for Patients Undergoing Reconstructive Surgery of the Breast (1993) (31)
Challenges in ductal carcinoma in situ risk communication and decision‐making (2012) (31)
Late onset dilated cardiomyopathy in a unique familial syndrome of hypogonadism and metabolic abnormalities. (1987) (30)
Flat epithelial atypia (2012) (30)
Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case–Control Study (2015) (30)
Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies (2016) (30)
Clinical and Pathologic Features of Breast Cancers in Women Treated for Hodgkin's Disease: A Case‐Control Study (2001) (29)
Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age: An Analysis of 657 Patients (2009) (29)
Role of the Surgical Pathologist in the Diagnosis and Management of the Cancer Patient (2003) (28)
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer (2016) (28)
Alcohol consumption and incidence of benign breast disease. (2002) (28)
Granulomatous inflammation of minor salivary gland ducts: a new oral manifestation of Crohn's disease. (1987) (28)
Will Molecular Classification Replace Traditional Breast Pathology? (2010) (28)
Pan-TRK Immunohistochemistry (2019) (27)
Evaluation of breast biopsy specimens in patients considered for treatment by conservative surgery and radiation therapy for early breast cancer. (1988) (27)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020) (27)
Histololfic analysis of directional coronary atherectomy samples (1993) (27)
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting (2009) (27)
The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy. (1989) (27)
Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics. (2010) (26)
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group (2020) (26)
p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast. (2007) (25)
Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study (2017) (25)
Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue (2017) (25)
Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer. (1989) (25)
Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer Patients (1999) (24)
Pathologic features of breast cancers in women with previous benign breast disease. (2001) (24)
Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. (1990) (24)
Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ (2019) (24)
Massive mural edema in severe pseudomembranous colitis. (1983) (23)
Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS) (2018) (23)
Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy (1993) (23)
Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology (2014) (23)
Conservative surgery and radiotherapy for early breast cancer (1986) (23)
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case–control study (2005) (23)
Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers (2014) (22)
Lifetime physical activity and the incidence of proliferative benign breast disease (2011) (22)
The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. (2015) (22)
Prognostic factors for patients with breast cancers 1cm and smaller. (1998) (22)
Digitized Whole Slides for Breast Pathology Interpretation: Current Practices and Perceptions (2014) (22)
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies (2017) (22)
Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity (2019) (22)
Benign breast disease and breast cancer risk: potential role for antiestrogens. (2001) (22)
The relationship between pathologic margin status and outcome after breast-conserving therapy (1998) (21)
Early ostial vein graft stenosis: management by atherectomy. (1991) (21)
Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk (2019) (21)
Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers (2015) (21)
Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease (2012) (20)
Benign breast lesions that mimic malignancy. (2017) (20)
Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2014) (19)
Understanding the distribution of cancer within the breast is important for optimizing breast‐conserving treatment (1995) (19)
Therapy of in situ cancer. (1989) (19)
Management of ductal carcinoma in situ (1995) (19)
Molecular analysis of TCGA breast cancer histologic types (2021) (19)
Classification of ductal carcinoma in situ: striving for clinical relevance in the era of breast conserving therapy. (1997) (18)
Paget's disease with extensive involvement of the female genital tract initially detected by cervical cytosmear. (1988) (18)
Should intraoperative frozen section evaluation of breast lumpectomy margins become routine practice? (2012) (18)
Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. (2012) (18)
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk (2018) (17)
Tumor Structure and Tumor Stroma Generation (2003) (17)
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034) (2020) (17)
Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery (2018) (16)
Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2019) (16)
American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications. (2020) (16)
The relationship between positive microscopic margins of resection and the risk of local recurrence in patients with breast-conserving therapy (1992) (16)
Clinical and histologic aspects of proliferative and non‐proliferative benign breast disease (1993) (15)
Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. (2009) (15)
Treatment selection in ductal carcinoma in situ. (2000) (15)
Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. (2010) (14)
MIB‐1 Proliferation Index in Ductal Carcinoma In Situ of the Breast: Relationship to the Expression of the Apoptosis‐Regulating Proteins bcl‐2 and p53 (2000) (14)
Histopathologic findings in breast surgical specimens from patients undergoing female-to-male gender reassignment surgery (2018) (14)
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations (2020) (14)
Columnar cell lesions of the breast: pathological features and clinical significance (2004) (13)
Microwave fixation provides rapid, primary fixation for light and electron microscopy and for immunohistochemistry and immunocytochemistry. (1991) (13)
Evaluation of Breast and Axillary Lymph Node Specimens in Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy (2019) (13)
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer (2020) (13)
Craniopharyngioma in an elderly patient (1987) (13)
Histologic analysis of directional coronary atherectomy samples. A review of findings and their clinical relevance. (1993) (13)
Columnar Cell Lesions and Flat Epithelial Atypia of the Breast (2005) (13)
The increasing prevalence of benign proliferative breast lesions in Japanese women (1993) (12)
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study (2021) (12)
Artificial intelligence applied to breast pathology (2021) (12)
Society of Surgical OncologyeAmerican Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2015) (12)
Pathologic Features and Immunophenotype of Estrogen Receptor–positive Breast Cancers in BRCA1 Mutation Carriers (2012) (12)
Can we identify patients with invasive breast cancer adequately treated with breast-conserving surgery alone? (1998) (12)
137 A prospective trial of conservative surgery (CS) alone without radiation therapy (RT) in selected patients with early-stage breast cancer (1995) (12)
Vascular lesions of the breast. (2017) (11)
Retinoblastoma protein expression and its predictors in triple-negative breast cancer (2020) (11)
Clinging carcinoma: an American perspective. (2010) (11)
Prognostic factors for patients with breast cancers 1cm and smaller (2004) (11)
Evolution of breast-conserving therapy for localized breast cancer. (2008) (11)
Spindle Cell Lesions of the Breast. (2009) (10)
Molecular Biology of Breast Tumor Progression: A View From the Other Side (2010) (10)
Testosterone therapy and breast histopathological features in transgender individuals (2020) (10)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials (2020) (10)
Response to Correspondence Re: Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of Pathologic Prognostic Factors in Breast Core Needle Biopsies. Mod Pathol 1999;12:941–5 (2000) (9)
What to do about mammographically detected ductal carcinoma in situ? (1992) (9)
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk (2020) (9)
Genotype-Phenotype Correlations in Breast Cancer. (2017) (8)
Expression of Interleukin-1b in Human Breast Carcinoma (1997) (8)
Potential Role of Tissue Microarrays for the Study of Biomarker Expression in Benign Breast Disease and Normal Breast Tissue (2009) (8)
Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision (2021) (8)
Dilemmas in Breast Disease. Evaluation of Microscopic Margins in Patients with Invasive Breast Cancer: Technical and Interpretive Considerations (1998) (7)
Pathologic Factors Predictive of Local Recurrence in Patients with Invasive Breast Cancer Treated by Conservative Surgery and Radiation Therapy (1993) (7)
Uptake of hematoporphyrin derivative by valvular vegetations in experimental infective endocarditis. (1985) (7)
138 Pathologic margin involvement and the risk of recurrence inpatients treated with breast-conserving therapy (1995) (7)
Second non-breast malignancies after conservative surgery (CS) and radiation therapy (RT) for early-stage breast cancer (2000) (7)
Evaluation of Cytolyt and PreservCyt as Preservatives for Immunocytochemistry for Cytokeratin in Fine Needle Aspiration (1998) (7)
Problematic issues in breast core needle biopsies (2019) (7)
Morphologic changes in primary neuroendocrine carcinoma of the skin following radiation therapy. (1986) (7)
Morphologic Risk Factors for Local Recurrence in Patients with Invasive Breast Cancer Treated with Conservative Surgery and Radiation Therapy (1997) (7)
Recurrence of breast carcinoma as Paget disease of the skin at a prior core needle biopsy site: Case report and review of the literature (2015) (7)
A prospective study of endometriosis and risk of benign breast disease (2016) (7)
Retinoblastoma (Rb) protein expression in triple-negative breast cancer. (2017) (6)
The Real Value of Angiogenesis Research in Breast Cancer (1997) (6)
Breast carcinomas of low malignant potential (2021) (6)
Important Inflammatory and Reactive Lesions of the Breast. (2012) (6)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials (2020) (6)
Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization (2021) (6)
Comprar Biopsy Interpretation of the Breast | Laura C. Collins | 9781451113013 | Lippincott Williams & Wilkins (2012) (6)
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies (2017) (6)
Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact. (2020) (6)
Lumpectomy margins and much more—reply (1997) (6)
Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community (2016) (6)
Correspondence re: N. Azumi, J. Joyce, and H. Battifora. Does rapid microwave fixation improve immunohistochemistry? Mod Pathol 3:368, 1990. (1991) (6)
Time-course of local recurrence following conservative surgery (S) and radiotherapy (RT) for breast cancer (1987) (6)
Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer (2020) (6)
SAMPLING GROSSLY BENIGN BREAST BIOPSY SPECIMENS (1989) (6)
Endomyocardial biopsy: is it of clinical value? (1992) (5)
7 Predictors of local recurrence following excision alone for ductal carcinoma in situ (DCIS) (1997) (5)
Segal and Dowsett , p . 1724 Emergence of Constitutively Active Estrogen Receptor-a Mutations in Pretreated Advanced Estrogen Receptor – Positive Breast Cancer (2014) (5)
Prognosis following breast recurrence after conservative surgery (S) and radiotherapy (RT) for early stage breast carcinoma (1987) (5)
Prognosis of pathologic T1 infiltrating cancer of the breast (1993) (5)
Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue (2008) (5)
Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay (2018) (5)
Retinoblastoma protein expression and its predictors in triple-negative breast cancer (2020) (5)
Pharmacopathology: a new spin on an old idea. (2003) (5)
Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy (2020) (5)
Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast (2005) (5)
Refining Risk Assessment in Women With Benign Breast Disease: An Ongoing Dilemma. (2017) (4)
Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947–2009) (2015) (4)
Comprar Biopsy Interpretation of The Breast | Stuart J Schnitt | 9780781791465 | Lippincott Williams & Wilkins (2009) (4)
Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease (2014) (4)
Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib? (2021) (4)
Lipogranulomas in lymph nodes. (1986) (4)
1MO Prognostic and biologic significance of HER2-low expression in early breast cancer (2022) (3)
Microinvasive Carcinoma of the Breast (1998) (3)
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (2022) (3)
Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy (2021) (3)
Mucin Neovascularization as a Diagnostic Aid to Distinguish Mucinous Carcinomas From Mucocele-like Lesions in Breast Core Needle Biopsies (2021) (3)
Local recurrence after breast‐conserving therapy for phyllodes tumors: A 15‐year retrospective review (2019) (3)
Definition of an extensive intraductal component (2001) (3)
The ultrasound appearance of granular cell tumor of the breast: A case report (1994) (3)
Reply to breast cancer risk by the extent and type of atypical hyperplasia (2016) (3)
Abstract GS6-03: Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in germline BRCA mutation carriers (BRCAcarriers) with HER2-negative breast cancer: Results from the INFORM trial (TBCRC 031) (2020) (3)
Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies (2022) (2)
Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging. (2021) (2)
Luminal B breast tumors are not HER2 positive – authors' response (2008) (2)
Reply to Rosen (2017) (2)
Prevalence and predictors of androgen receptor (AR) and programmed death-ligand 1 (PD-L1) expression in BRCA1-associated and sporadic triple negative breast cancer (TNBC). (2015) (2)
Tissue Reactions to Mammary Implants: A Capsule Summary (1995) (2)
Breast Pathology: Diagnostic Dilemmas. (2012) (2)
2039 The relationship between the presence and extent of lobular carcinoma in situ (LCIS) and the risk of local recurrence (LR) in patients with infiltrating cancer of the breast treated with conservative surgery (CS) and radiation therapy (RT) (1997) (2)
2001 Risk of local failure in breast cancer patients with 4 or more positive lymph nodes treated with breast-conserving therapy (1995) (2)
Expression of estrogen receptor , progesterone receptor , and Ki 67 in normal breast tissue in relation to subsequent risk of breast cancer (2017) (2)
Assessing breast terminal duct lobular unit involution: a computational pathology approach: Poster No. 103 (2019) (2)
Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity (2022) (2)
1063 The significance of axillary extracapsular extension in breast cancer (1996) (2)
DNA repair protein biomarkers in triple negative breast cancer. (2009) (2)
Abstract S3-06: Emergence of constitutively active estrogen receptor mutations in advanced estrogen receptor positive breast cancer (2013) (2)
Is radiotherapy as curative as mastectomy for patients with ductal carcinoma in situ? (1990) (2)
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old? (2018) (2)
The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease (2021) (1)
Current topics in breast pathology: expert perspectives. (2017) (1)
Abstract P1-15-03: Eight-Year Update of a Prospective Study of Wide Excision Alone for Ductal Carcinoma In Situ (DCIS) of the Breast (2010) (1)
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study (2021) (1)
The impact of young age on outcome after breast-conserving surgery (BCS) and radiation therapy (RT) for Carcinoma in situ of the breast (DCIS) (2000) (1)
Abstract S2-02: The landscape of somatic genetic alterations in BRCA1 and BRCA2 breast cancers (2016) (1)
Abstract PS18-02: Highly multiplexed tissue-based cyclic immunofluorescence (t-CyCIF) for precision oncology identifies novel patterns of HER2 heterogeneity in breast cancer (2021) (1)
Images in Pathology (2003) (1)
Characterization of estrogen receptor-positive breast cancers inBRCA1mutation carriers. (2009) (1)
SAMPLING GROSSLY BENIGN BREAST BIOPSY SPECIMENS (1989) (1)
5 Family history suggestive of an inherited susceptibility to breast cancer and treatment outcome in young women after breast-conserving therapy (1997) (1)
Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue (2017) (1)
Radial Scars in Breast Biopsies: Pathologic Features and Clinical Importance (1999) (1)
Abstract P2-12-01: Comprehensive genomic profiling of 34 cases of breast angiosarcoma (2017) (1)
141 Breast-conserving therapy (BCT) in stage I–II synchronous bilateral breast cancer (SBBC) (1995) (1)
Impact of surgery-to-radiotherapy interval (SRI) on local control in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving therapy (BCT) (2004) (1)
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer (2022) (1)
Eight-Year Update of a Prospective Study of Wide Excision Alone for Ductal Carcinoma In Situ of the Breast (2011) (1)
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. (2009) (1)
Impact of residual nodal disease burden on sentinel node mapping and accuracy of intraoperative frozen section in node positive (cN1) breast cancer patients treated with neoadjuvant chemotherapy (NAC). (2018) (1)
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group (2021) (1)
The predictive value of HER2 and p53 on outcomes after paclitaxel chemotherapy for metastatic breast cancer: Results from CALGB 9342. (2004) (1)
p-120 Catenin is a Useful Diagnostic Biomarker for Distinguishing Plasmacytoid and Sarcomatoid Variants From Conventional Urothelial Carcinoma. (2020) (1)
Contemporary issues in breast pathology (2022) (1)
Imaging , Diagnosis , Prognosis DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer (2010) (0)
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98 (2019) (0)
Abstract 138: Solid papillary carcinoma with reverse polarization are driven by IDH2 and PI3K pathway mutations (2016) (0)
Does the extent of lymphatic vessel invasion (LVI) affect outcome in cT1pN0 breast cancer patients treated with conservative surgery (CS) and radiation therapy (RT) (2001) (0)
Abstract CT142: TALAVE: Induction talazoparib (tala) followed by combined tala and avelumab in patients (pts) with advanced breast cancer (ABC) (2023) (0)
Brest Images. Extracapsular Silicone Breast Implant Rupture Mimicked by the Sternalis Muscle (1998) (0)
S6-1 The Clinical Significance of HER-2/neu Detection (2002) (0)
Abstract P4-06-01: Using multi-omic profiling to unravel the complexity of triple-negative breast cancer (TNBC) (2020) (0)
Evaluation of outcome after breast conservation therapy (BCT) in patients with stage I and II tubular, mucinous and medullary breast carcinoma (2002) (0)
21 Is radiation alone adequate treatment to the axilla for patients with inadequate axillary dissection?: Implications for treatment after a positive sentinel node biopsy (1999) (0)
Abstract B067: Taxonomy of breast cancer based on normal cell phenotype and ontology (2013) (0)
Abstract 2313: Differences in estrogen receptor signaling in normal mammary epithelial cells and ER-positive primary breast tumors and metastases. (2013) (0)
Abstract PD3-05: The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease (2020) (0)
1028 A prospective trial of conservative surgery (CS) without radiation therapy (RT) for early-stage breast cancer (1995) (0)
NR4A3 Expression is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift. (2023) (0)
Seminars in Breast Disease: Introduction (2004) (0)
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old? (2018) (0)
Case selection does not permit conclusions. (1988) (0)
How repoducible is the diagnosis of flat epithelial atypia of the breast (2005) (0)
ASO Visual Abstract: Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision (2021) (0)
Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC) (2022) (0)
Abstract LB-265: Mutations in BRCA1 impair breast epithelial differentiation through the transcriptional repressor Slug (2010) (0)
Abstract 4207: Androgen receptor expression and ER+ breast cancer prognosis in the BIG 1-98 trial (2018) (0)
Inherited Syndromes, Li-Fraumeni Syndrome (2012) (0)
Abstract P2-09-25: Clinical and pathologic characteristics of breast cancers determined to be HER2-positive by fluorescence in-situ hybridization (FISH) using alternative chromosome 17 probes (2018) (0)
Table 35-3, Antigens with Highly Restricted Specificity (2003) (0)
The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease (2021) (0)
Angiosarcoma of the Mammary Skin Following Conservative Surgery and Radiation Therapy for Breast Cancer (1999) (0)
The Influence of Pathologic Features on Clinical Outcome of Breast Cancer Patients Treated by Primary Radiation Therapy (1986) (0)
Benign Breast Disease Intakes of Alcohol and Folate During Adolescence and Risk of Proliferative (2012) (0)
Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay (2018) (0)
Reporting of Estrogen Receptor Results: Back to the Future? (2006) (0)
Advances in Immunohistochemistry (1989) (0)
Abstract 4632: Automated quantitative measures of terminal duct lobular unit involution and breast cancer risk (2020) (0)
Falsely Low Carboxyhemoglobin Level after Hydroxocobalamin (2012) (0)
Advances in Brief Psoriasin Expression in Mammary Epithelial Cells in Vitro and in Vivo 1 (2001) (0)
Abstract P5-02-03: Highly multiplexed tissue-based cyclic immunofluorescence in breast cancer for precision oncology (2020) (0)
Harvey Goldman, MD (1932-2009) (2009) (0)
Local Recurrence After Breast-Conserving Treatment: Results from the Harvard Joint Center for Radiation Therapy (1989) (0)
P4-11-02: Insulin-Like Growth Factor-1 (IGF-1), Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) and Lobule Type among Women in the Nurses' Health Study II (NHS II). (2011) (0)
Abstract PS1-22: Differences in Treatment of Ductal Carcinoma In Situ by Race/ Ethnicity in Large Integrated Health Plans (2008) (0)
Abstract P5-02-02: Artificial intelligence powered predictive analysis of atypical ductal hyperplasia from digitized pathology images (2020) (0)
A New Spin on an Old Idea (2002) (0)
Comprar Current Concepts in Breast Pathology: Diagnostic Dilemmas and New Insights, An Issue of Surgical Pathology Clinics | Sandra Shin | 9781455739424 | Saunders (2012) (0)
LUMPECTOMY MARGINS AND MUCH MORE. AUTHOR'S REPLY (1997) (0)
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk (2018) (0)
ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS (2022) (0)
The impact of pattern of tumor response and other post-treatment histologic features on local recurrence in patients treated with neoadjuvant chemotherapy and breast conservation. (2020) (0)
Title: Evolutionary pathways in BRCA1-associated breast tumors (2012) (0)
44 The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy (1996) (0)
Abstract P5-02-09: Quantitative analysis of fiber-level collagen features in H&E whole-slide images predicts neoadjuvant therapy response in patients with HER2+ breast cancer (2023) (0)
651 Apoptosis accounts for the necrosis seen in DCIS (1995) (0)
Breast epithelial differentiation is altered in BRCA1mut/+ carriers prior to the onset of cancer and contributes to the basal tumor phenotype. (2009) (0)
TDLU Involution and Breast Cancer Risk—Reply (2021) (0)
In Reply. (2016) (0)
Abstract LB-179: Expression of estrogen receptor, progesterone receptor, and ki67 in normal breast tissue and subsequent risk of breast cancer (2015) (0)
Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease (2014) (0)
Abstract 2782: Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer (2010) (0)
Estrogen Rececptor (ER)-Positive Breast Cancers inBRCA1Mutation Carriers: Mutation-Related or Sporadic?: (2009) (0)
S15 Shifting knowledge on in situ carcinomas: The pathologist's view (1998) (0)
Abstract PR09: Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the status of selected tissue markers: A case-control study (2013) (0)
The Pathologists' Conundrum. (2022) (0)
139 Relationship of tumor grade to other pathologic features and to treatment outcome for patients with early-stage breast cancer treated with breast-conserving therapy (1995) (0)
Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome? (2023) (0)
Abstract P6-04-13: Centralized adequacy assessment of ductal carcinoma in situ samples for the COMET study (AFT-25) (2023) (0)
Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals. (2023) (0)
Ensuring remote diagnostics for pathologists: an open letter to the US Congress (2022) (0)
Abstract ES1-1: What is a HER2-positive in breast cancer in 2018? (2019) (0)
FNA identification of familial breast disease. (1992) (0)
Abstract P2-14-18: A randomized phase II trial of carboplatin with or without nivolumab in metastatic triple-negative breast cancer (2022) (0)
Abstract PS6-07: Comparison of breast cancer staging models in patients after neoadjuvant chemotherapy (2021) (0)
Abstract P5-02-02: Second harmonic generation in combination with nuclear morphometry in the evaluation of DCIS (2018) (0)
Abstract 4295: Androgen receptor expression in normal breast TDLUs and subsequent breast cancer risk (2016) (0)
4420 s Benign Breast Disease and Breast Cancer Risk Table 1 Relative risk of breast cancer according to histologic category of benign breast disease in studies using the criteria of Dupont (2007) (0)
Assessment of standard prognostic factors in breast core needle biopsies (1999) (0)
Abstract 916: BRCA1 mutations impair breast epithelial differentiation through upregulation of the transcriptional repressor Slug (2011) (0)
Evaluation of margins in invasive carcinoma and ductal carcinoma in situ: The pathologist's perspective. (2017) (0)
The tumor-immune microenvironment (TME) in HR+/HER2- metastatic breast cancer (mBC): Relationship to non-metastatic (met) tumors and prior treatment (tx) received. (2018) (0)
Abstract 3637: Repressive histone marks in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study. (2013) (0)
c-erbB-2 Oncogene expression in relation to the extent of the intraductal component in invasive ductal carcinomas (1993) (0)
ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer (2022) (0)
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS (2022) (0)
Abstract PD01-08: Differences in estrogen receptor signaling in non-malignant primary ER-positive breast epithelial cells and breast cancer. (2012) (0)
The authors' reply. (2019) (0)
Evaluation of margins in invasive carcinoma and DCIS: the pathologist’s perspective (2017) (0)
Deep learning networks to segment and detect breast terminal duct lobular units, acini, and adipose tissue: a step toward the automated analysis of lobular involution as a marker for breast cancer risk (2019) (0)
Cancer Positive Breast − in Pretreated Advanced Estrogen Receptor Mutations α Emergence of Constitutively Active Estrogen Receptor-Updated (2014) (0)
Abstract ES02-1: Pathology and biology of early breast lesions (2013) (0)
P5-01-13: High Levels of Nuclear Heat Shock Factor 1 (HSF1) Are Associated with Poor Prognosis in Breast Cancer: Results from the Nurses' Health Study. (2011) (0)
Recent advances in breast cancer (2016) (0)
Anatomic Pathology / BREAST CANCERS AFTER BENIGN BIOPSY DIAGNOSES (2002) (0)
Smooth muscle cell proliferation, growth and migration in primary and restenotic human coronary atherosclerotic tissue (1996) (0)
ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization (2021) (0)
3–6 Magnetic Resonance Evaluation of the Presence of an Extensive Intraductal Component in Breast Cancer (2005) (0)
Distant recurrences in triple negative breast cancer (TNBC) according to androgen receptor (AR) status. (2016) (0)
Abstract P5-12-03: Intratumor heterogeneity and intrinsic immune activation are associated with response to chemotherapy in BRCA-related breast cancers (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stuart J. Schnitt?

Stuart J. Schnitt is affiliated with the following schools:

University of Texas Health Science Center at San Antonio
Massachusetts General Hospital
University of Cambridge